Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,767,364,935
-
Number of holders
-
2954
-
Total 13F shares, excl. options
-
1,188,323,728
-
Shares change
-
+7,022,329
-
Total reported value, excl. options
-
$160,862,723,207
-
Value change
-
+$1,040,998,406
-
Put/Call ratio
-
66.15%
-
Number of buys
-
1,450
-
Number of sells
-
-1,005
-
Price
-
$135.4
Significant Holders of AbbVie Inc. - Common Stock (ABBV) as of Q4 2021
3,139 filings reported holding ABBV - AbbVie Inc. - Common Stock as of Q4 2021.
AbbVie Inc. - Common Stock (ABBV) has 2,954 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,188,323,728 shares
of 1,767,364,935 outstanding shares and own 67.24% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (146,312,069 shares), BlackRock Inc. (128,197,550 shares), STATE STREET CORP (79,357,705 shares), JPMORGAN CHASE & CO (43,104,988 shares), PRICE T ROWE ASSOCIATES INC /MD/ (32,585,913 shares), GEODE CAPITAL MANAGEMENT, LLC (28,518,946 shares), NORTHERN TRUST CORP (22,817,526 shares), Bank of New York Mellon Corp (21,384,827 shares), BANK OF AMERICA CORP /DE/ (20,394,772 shares), and FRANKLIN RESOURCES INC (19,817,057 shares).
This table shows the top 2954 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.